Vascular endothelium as a major participant in T-lymphocyte immunity.
暂无分享,去创建一个
[1] A. Hamblin,et al. Endothelial cell presentation of antigen to human T cells. , 1981, Human immunology.
[2] H. Hirschberg. Presentation of viral antigens by human vascular endothelial cells in vitro. , 1981, Human immunology.
[3] P. Lipsky,et al. Human endothelial cell-lymphocyte interaction. Endothelial cells function as accessory cells necessary for mitogen-induced human T lymphocyte activation in vitro. , 1981, The Journal of clinical investigation.
[4] M. A. Bray,et al. LEUKOTRIENE B4: A MEDIATOR OF VASCULAR PERMEABILITY , 1981, British journal of pharmacology.
[5] R. Clark,et al. Fibronectin in delayed-type hypersensitivity skin reactions: associations with vessel permeability and endothelial cell activation. , 1981, Journal of immunology.
[6] E. Thorsby,et al. HLA-D region products are expressed in endothelial cells. , 2008, Tissue antigens.
[7] J. Streilein,et al. Ia antigens and epidermal Langerhans cells. , 1980, Transplantation.
[8] W. Duncan,et al. IMMUNOGENETIC RELATIONSHIPS AMONG GENETICALLY DEFINED, INBRED DOMESTIC SYRIAN HAMSTER STRAINS , 1980, Transplantation.
[9] R. Schwartz,et al. Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice , 1980, The Journal of experimental medicine.
[10] M. A. Bray,et al. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes , 1980, Nature.
[11] T. Flotte,et al. Langerhans cells as macrophages in skin and lymphoid organs. , 1980, The Journal of investigative dermatology.
[12] E. Thorsby,et al. SPECIFIC DESTRUCTION OF HUMAN ENDOTHELIAL CELL MONOLAYERS BY ANTI‐DRw ANTISERA , 1979, Transplantation.
[13] D. D. Bono. Endothelium-lymphocyte interactions in vitro: II. Adherence of allergized lymphocytes , 1979 .
[14] T. J. Williams,et al. PROSTAGLANDIN E2, PROSTAGLANDIN I2 AND THE VASCULAR CHANGES OF INFLAMMATION , 1979, British journal of pharmacology.
[15] E. Thorsby,et al. Complement and cell-mediated specific destruction of human endothelial cells treated with anti-DRw antisera. , 1979, Transplantation Proceedings.
[16] E. Shevach,et al. Analogous functions of macrophages and Langerhans cells in the initiation in the immune response. , 1978, The Journal of investigative dermatology.
[17] E. Jaffe,et al. Synthesis of fibronectin by cultured human endothelial cells , 1978, Annals of the New York Academy of Sciences.
[18] J. Pearson,et al. Localisation and stimulation of prostacyclin production in vascular cells , 1978, Nature.
[19] R. Messner,et al. Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell , 1977, The Journal of experimental medicine.
[20] P. Stastny,et al. A new antigen system expressed in human endothelial cells. , 1977, The Journal of clinical investigation.
[21] J. Vane,et al. Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides. , 1976, Prostaglandins.
[22] D. D. Bono. Endothelial-lymphocyte interactions in vitro. I. Adherence of nonallergised lymphocytes. , 1976 .
[23] E. Jaffe,et al. Synthesis of basement membrane collagen by cultured human endothelial cells , 1976, The Journal of experimental medicine.
[24] E. Thorsby,et al. THE HUMAN MIXED LYMPHOCYTE‐ENDOTHELIUM CULTURE INTERACTION , 1975, Transplantation.
[25] Vetto Rm,et al. Endothelial cell stimulation of allogeneic lymphocytes. , 1972 .
[26] E. Unanue. The regulatory role of macrophages in antigenic stimulation. , 1972, Advances in immunology.
[27] Vetto Rm,et al. The identification and comparison of transplantation antigens on canine vascular endothelium and lymphocytes. , 1971 .